Varian Medical Systems Director Richard Levy Unloads 20,000 Shares (VAR)
Varian Medical Systems (NYSE:VAR) Director Richard Levy sold 20,000 shares of Varian Medical Systems stock on the open market in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $77.68, for a total transaction of $1,553,600.00. The sale was disclosed in a document filed with the SEC, which is available at this link.
Varian Medical Systems (NYSE:VAR) traded up 0.18% on Friday, hitting $77.48. The stock had a trading volume of 633,948 shares. Varian Medical Systems has a 1-year low of $63.10 and a 1-year high of $80.66. The stock’s 50-day moving average is $76.86 and its 200-day moving average is $73.65. The company has a market cap of $8.191 billion and a P/E ratio of 19.43.
Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, October 23rd. The company reported $1.08 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.12 by $0.04. The company had revenue of $770.00 million for the quarter, compared to the consensus estimate of $779.02 million. During the same quarter in the prior year, the company posted $1.08 earnings per share. The company’s quarterly revenue was up 1.8% on a year-over-year basis.
VAR has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Varian Medical Systems in a research note to investors on Tuesday, December 10th. They now have a $83.00 price target on the stock. Finally, analysts at Jefferies Group raised their price target on shares of Varian Medical Systems from $78.00 to $80.00 in a research note to investors on Thursday, October 24th. They now have a “buy” rating on the stock. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company’s stock. Varian Medical Systems presently has an average rating of “Hold” and an average target price of $74.90.
Varian Medical Systems, Inc is engaged in the design, manufacture, sale and service of equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy (NYSE:VAR), stereotactic radiosurgery (SRS) and brachytherapy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.